Influence of age and prostate-specific antigen on the chance of curable prostate cancer among men with nonpalpable disease
Authors:
- Jonathan I EpsteinJEJonathan I Epstein
- Alan W PartinAPAlan W Partin
Open Access
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Prostate Cancer Detection in Men With Serum PSA Concentrations of 2.6 to 4.0 ng/mL and Benign Prostate ExaminationJAMA, 1997
- Age-Specific Reference Ranges for Serum Prostate-Specific Antigen in Black MenNew England Journal of Medicine, 1996
- Prediction of Progression Following Radical ProstatectomyAmerican Journal of Surgical Pathology, 1996
- Prospective characterization of pathological features of Prostatic Carcinomas Detected Via Serum Prostate Specific Antigen Based ScreeningJournal of Urology, 1996
- Diagnosis of advanced or noncurable prostate cancer can be practically eliminated by prostate-specific antigenUrology, 1996
- Comparison of Digital Rectal Examination and Serum Prostate Specific Antigen in the Early Detection of Prostate Cancer: Results of a Multicenter Clinical Trial of 6,630 MenJournal of Urology, 1994
- Serum Prostate-Specific Antigen in a Community-Based Population of Healthy MenJAMA, 1993
- Influence of Capsular Penetration on Progression Following Radical Prostatectomy: A Study of 196 Cases with Long-Term FollowupJournal of Urology, 1993
- Screening for Cervical CancerAnnals of Internal Medicine, 1990
- Pathological Stage is Higher in Older Men with Clinical Stage B1 Adenocarcinoma of the ProstateJournal of Urology, 1989